Hutch News
Results per Page:
Enhance, enhance! Computational tool “BayesSpace” zooms in to fine-map spatial transcriptomics
From the Gottardo, Bielas, and Nghiem Labs, Biostatistics and Computational Biology Program, Cancer Consortium
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma
Pembrolizumab treatment for Merkel cell carcinoma
From the Nghiem Laboratory, Clinical Research Division
On immunotherapy trial, long-term survivors of deadly skin cancer point to a hopeful future
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma
Seattle team pivotal to FDA OK on drug for rare skin cancer
UW Medicine and Fred Hutch had key roles in clinical trial of immunotherapy option for often-lethal Merkel cell cancer
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
Galloway receives NCI Outstanding Investigator Award
Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers
Triple therapy for rare skin cancer shows promise in small, early-stage trial
Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer
Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma
Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer
Benefit seen in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma
Immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care
Study found long-lasting responses to immunotherapy drug in patients with Merkel cell carcinoma
New project: CAR T cells for HIV cure?
Dr. Larry Corey wins $2.6M grant to investigate immunotherapy's potential to bring about long-term HIV remission
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
A new blood test detects recurrence of rare skin cancer
$200 assay can accurately signal return of Merkel cell carcinoma — in some cases catching tumors earlier than expensive imaging